Best Life Sciences Platforms and Tools Companies in San Diego, United States
The 190 best Life Sciences Platforms and Tools companies in San Diego, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Element Biosciences.
Our analysis of 50 Life Sciences Platforms and Tools companies
$4.8b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Platforms and Tools companies in San Diego
| # | Company | Disclosed funding | Last round | Employees | Founded | Tech stack | Web popularity | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Element Biosciences 🦄 Developer of benchtop DNA sequencer for research applications 84Innovation top 10%Patents top 13%Funding top 16%Moat top 22% All 11 signals ▾Innovationtop 10% Patentstop 13% Fundingtop 16% Moattop 22% Markettop 35% Growthtop 35% Talenttop 38% Producttop 41% Techtop 45% Globalbottom 47% Newsbottom 24% Innovation: 554 patents (top 4% of patent-holders) · 469 filings since 2022 vs 85 in 2017-21 Patents: 554 patents matched (strict assignee match) · 469 filings since 2022 vs 85 in 2017-21 rank vs industry peers · Fliar Intelligence Index 84/100 | $678M | 23 mo ago | 318 | 2017 | HubSpot CMS HubVimeoAnimate.css+20 | Top 5M | 554 patents Advanced optical flow cells, reagents, and data processing for next‑gen DNA sequencing | 1 job opening |
| 2 | Sapphire Energy Business energy price comparison website helping UK businesses save on energy bills | $390M | 126 mo ago | 1 | 2006 | — | — | 269 patents Algal biofuel production and photosynthetic synthesis of high‑value chemicals. | — |
| 3 | Denovo Biopharma Developer of genomic biomarker discovery platform | $172M | 66 mo ago | 42 42 → 28 (-33%) | 2013 | — | — | 50 patents Predictive biomarkers and assays for nucleic‑acid therapeutics and neuro‑transporter drug efficacy | — |
| 4 | Omniome Provider of genome sequencing platform | $160M | 78 mo ago | 164 | 2013 | — | — | 267 patents High-throughput nucleic acid sequencing, analysis, and engineered polymerase technologies | — |
| 5 | Expansion Therapeutics Provider of a software system for the development of drugs | $140M | 56 mo ago | 20 | 2016 | — | — | — | — |
| 6 | Tentarix Developer of protein-based therapeutics solutions for the discovery of multi-specific biologics | $132M | 33 mo ago | 29 | 2011 | — | — | — | — |
| 7 | Bionano Provider of genome analysis solutions to researchers and clinicians | $124M | 24 mo ago | 364 | 2002 | WordPressMySQLPHP+25 | Top 5M | 43 patents Iron‑based nanomaterials and nanoemulsion formulations for pharmaceutical delivery | — |
| 8 | Debut Provider and manufacturer of enzymes for biotherapeutic creation and modification 35Funding top 21%Moat top 31%News top 34%Tech bottom 49% All 7 signals ▾Fundingtop 21% Moattop 31% Newstop 34% Techbottom 49% Talentbottom 48% Globalbottom 45% Marketbottom 31% Funding: Raised $106M across 7 rounds · 7 rounds over 6 yrs (1.2/yr) Moat: Editorial + unicorn rating 8/10 · Soonicorn rank vs industry peers · Fliar Intelligence Index 35/100 | $106M | 9 mo ago | 18 | 2019 | WebflowSentryApple iCloud Mail+15 | Top 10M | — | 1 partnership |
| 9 | Molecular Assemblies Provider of an enzymatic DNA synthesis product for researchers | $78M | 51 mo ago | 21 | 2013 | — | — | 91 patents Automated synthesis of DNA/RNA using reusable initiators and engineered enzymes | — |
| 10 | NanoCellect Biomedical Develops flow cytometry and cell sorting technology | $78M | 35 mo ago | 84 | 2009 | WordPressMySQLPHP+17 | Top 10M | 30 patents Microfluidic cell sorting and flow cytometry instrumentation for high‑throughput particle analysis | — |
| 11 | Synthetic Genomics Provides a variety of synthetic genomic solutions. | $75M | 126 mo ago | 190 | 2005 | — | — | 789 patents Genetically engineered algae for high‑lipid, high‑productivity biofuel and bioproduct synthesis | — |
| 12 | Encodia Developer of technology platforms for integrative proteomic analysis | $75M | 64 mo ago | 85 | 2015 | — | — | 194 patents Nucleic‑acid‑encoded macromolecule/peptide analysis and barcoding technologies | — |
| 13 | GenomeDx Biosciences Genomic tests for urologic cancers | $70M | 73 mo ago | 159 | 2008 | — | — | — | — |
| 14 | Biological Dynamics Provider of molecular diagnostics plaform | $68M | 67 mo ago | 54 | 2010 | Cart FunctionalitySquarespace CommerceSquarespace+20 | Top 50M | 78 patents Biomedical diagnostics and biomarker detection, analyte data processing, dielectric materials, surface functionalization | — |
| 15 | Thesan Pharmaceuticals Developer of therapeutics for disorders of the skin | $65M | 147 mo ago | 5 | 2011 | — | — | — | — |
| 16 | Huya Bioscience International Globalizing China's biopharma innovation, accelerating drug development and maximizing value | $61M | 133 mo ago | 66 | 2004 | — | — | 68 patents Patents concentrated in health & consumer products | — |
| 17 | Mpex Pharmaceuticals Develops therapies for infectious diseases | $60M | 208 mo ago | 33 | 2001 | — | — | — | — |
| 18 | Replay Provider of genomic reprogramming platform for writing and delivering big DNA | $55M | 42 mo ago | 13 13 → 30 (+131%) | 2021 | ContentfulApple iCloud MailMicrosoft 365+13 | Top 50M | 46 patents Patents concentrated in chemistry & materials | — |
| 19 | Applied Proteomics Protein-based diagnostics for colorectal and esophageal cancer risk assessment | $50M | 152 mo ago | 17 | 2006 | — | — | 39 patents Proteomic biomarker panels for colorectal cancer and adenoma detection diagnostics | — |
| 20 | Cyntellect Cell analysis, purification, and processing technology | $49M | 193 mo ago | 13 | 1997 | — | — | 35 patents Targeted cell purification, manipulation, and analysis using laser and optoinjection technologies | — |
| 21 | Electronic Bio Provider of nanotech-based DNA sequencing solutions 10Funding top 37%Talent bottom 45%Global bottom 29%Market bottom 24% All 5 signals ▾Fundingtop 37% Talentbottom 45% Globalbottom 29% Marketbottom 24% Techbottom 15% Funding: Raised $40.7M across 49 rounds · 49 rounds over 19 yrs (2.6/yr) Talent: 1 named leader on record rank vs industry peers · Fliar Intelligence Index 10/100 | $41M | 12 mo ago | 15 | 2002 | — | — | — | — |
| 22 | Creyon Bio Provider of drug design and oligonucleotide-based drug development platform | $40M | 51 mo ago | 38 | 2019 | WordPressMySQLPHP+15 | Top 10M | — | — |
| 23 | ACEA Biosciences Developer of instruments for life science research | $38M | 99 mo ago | 5,968 | 2002 | — | — | 236 patents Small-molecule kinase inhibitors and related anticancer therapeutics for cellular and cardiac applications | — |
| 24 | Neothetics Therapeutics for spot reduction of unwanted fat and general body contouring. | $35M | 148 mo ago | 10 | 2007 | — | — | 25 patents Patents concentrated in health & consumer products | — |
| 25 | Roswell Provider of diagnostic sensor solutions for nucleic acid sequencing | $32M | 89 mo ago | 77 | 2015 | — | — | 20 patents Patents concentrated in computing, sensing & instrumentation | — |
| 26 | Stemedica Biopharmaceutical company developing progenitor cell and protein therapeutics for underserved medical… | $32M | 197 mo ago | 44 | 2005 | WordPressMySQLPHP+11 | Top 50M | — | — |
| 27 | Equillium Developer of therapies for treating autoimmune and inflammatory disorders | $30M | 10 mo ago | 36 36 → 38 (+6%) | 2017 | Q4MediaElement.jsMicrosoft ASP.NET+14 | Top 10M | 33 patents Immunotherapy antibodies targeting CD6 for autoimmune and inflammatory disease treatment | — |
| 28 | Zafrens Provider of single-cell multi-omics analysis platform for researchers | $29M | 16 mo ago | 19 19 → 30 (+58%) | 2021 | — | — | 6 patents Patents concentrated in computing, sensing & instrumentation | — |
| 29 | StemoniX Engineering human brain and nerve models for neurological insights | $29M | 73 mo ago | 13 | 2014 | — | — | 41 patents 3D human cell spheroid platforms for drug discovery and electrophysiological screening | — |
| 30 | Vala Sciences High-content kinetic screening technologies transforming cellular signals into actionable insights | $29M | 24 mo ago | 29 | 2004 | — | — | — | — |
| 31 | TriLink BioTech Developer of nucleic acid and mRNA products for research applications | $29M | 15 mo ago | 348 | 1996 | Cart FunctionalityMagentoApple iCloud Mail+38 | Top 5M | — | 3 launchs · 1 expansion · 1 award |
| 32 | Illumina Developer of technologies for analysis of genetic variation and function | $28M | 77 mo ago | 5,548 5,548 → 9,678 (+74%) | 1993 | Cart FunctionalityAdobe Experience ManagerApple iCloud Mail+32 | Top 500k | 10,583 patents High-throughput DNA sequencing hardware, reagents, and AI-driven base‑calling technologies | — |
| 33 | Biomatrica Develops assay reagents and samples for diagnostics manufacturers | $27M | 101 mo ago | 26 | 2004 | — | — | 147 patents Preserving blood components for hematology diagnostics and sample stability. | — |
| 34 | Mesa Biotech Provider of point-of-care molecular diagnostic kits | $27M | 67 mo ago | 131 | 2009 | — | — | 62 patents Point‑of‑care nucleic acid testing using microfluidic cartridge platforms. | — |
| 35 | Telesis Bio Online platform offering life sciences reagents and kits | $25M | 36 mo ago | 125 | 2013 | WordPressApple iCloud MailMySQL+29 | Top 10M | — | 1 job opening · 3 launchs |
| 36 | Direct Electron Developer of cameras for electron microscopy 57Innovation top 20%Growth top 35%Tech top 41%Funding top 42% All 8 signals ▾Innovationtop 20% Growthtop 35% Techtop 41% Fundingtop 42% Producttop 46% Talentbottom 45% Globalbottom 29% Marketbottom 23% Innovation: 11 product lines Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 57/100 | $25M | 13 mo ago | 13 | 2007 | WordPressMySQLPHP+34 | Top 5M | — | 1 launch |
| 37 | Epigen Biosciences Provider of drug discovery translation services | $24M | 13 mo ago | 13 | 2010 | — | — | 57 patents Small-molecule heterocyclic kinase inhibitors for S6K-mediated disease therapies | — |
| 38 | Immunicom Developer of a immunotherapy device | $22M | 48 mo ago | 41 | 2013 | — | — | 71 patents Cytokine capture ligands and extracorporeal apheresis for immunotherapy modulation | — |
| 39 | Cardea Bio Developer of digital graphene biosensors using ML | $22M | 49 mo ago | 27 | 2019 | — | — | — | — |
| 40 | Orphagen Pioneering small molecule therapies for cancer and inflammatory bowel disease | $12M | 18 mo ago | 7 | 2001 | — | — | — | — |
| 41 | VitriLife Thermostabilization platform enabling ambient storage of vaccines and sensitive biologics | $10M | 17 mo ago | 6 | 2002 | — | — | — | — |
| 42 | Diagnologix Developer of cell-processing systems to sort circulating tumor cells | $8M | 13 mo ago | — | 2012 | — | — | 13 patents Patents concentrated in chemistry & materials | — |
| 43 | AvantGen Antibody discovery and engineering company advancing antibody drugs for scientific partners | $8M | 10 mo ago | 11 | 2006 | — | — | 16 patents Therapeutic peptide ligands targeting immune receptors and SARS‑CoV‑2 viral proteins | — |
| 44 | Abilita Bio Focused on developing technologies to enable discovery and development of drugs targeting membrane proteins… | $8M | 39 mo ago | 13 | 2014 | — | — | — | — |
| 45 | Qureator Developer of micro physiological systems for drug discovery | $7M | 5 mo ago | 22 | 2020 | — | — | 7 patents Microfluidic chip architectures enabling rounded corners and perfusable vascular networks for organ‑on‑chip applications. | 1 job opening |
| 46 | AscentX Medical Regenerative medicine company focused on advanced tissue engineering and CMO services | $5M | 34 mo ago | 3 | 2008 | — | — | — | — |
| 47 | Defined Bioscience Developer of cell culture reagents, growth medium, and kits for cell-based assays | $2M | 14 mo ago | 6 | 2020 | Cart FunctionalityShopifyShop Pay+17 | Top 10M | — | 1 partnership |
| 48 | Abwiz Bio Custom monoclonal antibody development services for therapeutics and diagnostics | $1M | 22 mo ago | 11 | 2012 | — | — | — | — |
| 49 | Cybele Microbiome AI-powered platform offering prebiotics for skin care | $1M | 27 mo ago | 9 | 2017 | — | — | 19 patents Bioinformatics-driven skin‑care formulation and analysis of microbiome/genomic data | — |
| 50 | WinSanTor Developing nerve-regenerating treatments for peripheral neuropathy, improving patient lives | $783K | 14 mo ago | 5 | 2011 | WordPress Block EditorElementorWordPress+24 | Top 5M | 25 patents Topical pharmaceutical formulations for peripheral neuropathy pain and sexual sensory disorder treatment. | — |
Top 12 Life Sciences Platforms and Tools companies in San Diego
#1
Series B · San Diego, California · founded 2019 · 18 employees$105.8Mraised▾
Provider and manufacturer of enzymes for biotherapeutic creation and modification. The company offers a range of enzymes that are used in the biotech industry for immobilization and other therapeutic applications. The company also provides continuous biomanufacturing cartridges, immobilized cells, immobilized enzymes for continuous biomanufacturing.
- Aug 2025Series B$20M
- Oct 2023Series B$40M
- Jun 2023Series B—
- Jun 2023Series B$34M
#2
Series D · San Diego, California · founded 2017 · 318 employees$678.3Mraised▾
Developer of benchtop DNA sequencer for research applications. The company offers an AVITI benchtop sequencer that delivers high data quality through enhanced contrast-to-noise ratio (CNR) for the research and diagnostic markets.
- Jul 2024Series D$277M
- Jun 2021Series C$276M
- Jun 2020Series B$30M
- Jan 2020Series B$80.3M
#3
Funding Raised · San Diego, California · founded 2002 · 15 employees$40.7Mraised▾
Provider of nanotech-based DNA sequencing solutions. It offers systems for ion channel characterization, and chemical sensing and develops systems for nanopore and ion channel measurements. The instruments developed by the company aids with applications in DNA sequencing, ion channel characterization, and chemical sensing.
- May 2025Grant (prize money)$400K
- May 2025Grant (prize money)$350K
- Apr 2025Grant (prize money)$350K
- Mar 2025Grant (prize money)$386.5K
#4
Series A · San Diego, California · founded 2020 · 22 employees$6.7Mraised▾
Developer of micro physiological systems for drug discovery. It offers Curiochips designed for recapitulating the complexity of tissue microenvironments for microscale 3D cell culture conditions for a variety of applications in biomedical research.
- Dec 2025Series A$6.7M
#5
Public · San Diego, California · founded 2017 · 36 employees$30Mraised▾
Developer of therapies for treating autoimmune and inflammatory disorders. The lead product, itolizumab is a treatment for multiple severe immuno-inflammatory disorders, including graft-versus-host disease, uncontrolled moderate to severe asthma, and SLE / lupus nephritis.
- Aug 2025Post IPO$30M
#6
Funding Raised · San Diego, California · founded 2007 · 13 employees$24.5Mraised▾
Developer of cameras for electron microscopy. It is engaged in innovating in the field of camera technology and other tools for electron microscopy. It offers a detection device for transmission electron microscopy.
- May 2025Grant (prize money)$1.5M
- May 2025Grant (prize money)$1.9M
- Apr 2025Grant (prize money)$2.5M
- Feb 2023Grant (prize money)$3.5M
#7
Funding Raised · San Diego, California · founded 2010 · 13 employees$24Mraised▾
Provider of drug discovery translation services. Epigen Biosciences is using in-silico drug discovery methods along with computational design, scaffold-hopping, focused library synthesis, and screening. It works in a collaborative manner and identifies leads from academic institutes and translates them into a product.
- Apr 2025Grant (prize money)$2.2M
- Jun 2024Grant (prize money)$550.9K
- May 2023Grant (prize money)$448.1K
- Jan 2022Grant (prize money)$263.4K
#8
Funding Raised · San Diego, California · founded 2006 · 11 employees$7.8Mraised▾
Antibody discovery and engineering company advancing antibody drugs for scientific partners. They enable the discovery and optimization of novel antibody drugs, focusing on providing partners with what they need for the next stage of development. They offer a range of platforms, including AvantEpee, AvantSabre, AvantFoil, AvantGeneer, and AvantBunny, leveraging yeast display technology and a Germliner Library Collection to generate fully human antibodies with favorable properties. They also provide services for optimizing lead candidates and developing nonhuman reagent or diagnostic antibodies. Their expertise extends to licensing opportunities, such as their Natural Killer (NK) cell engager platform. They are dedicated to pioneering research and development in antibody therapeutics, with a focus on enhancing health and wellness.
- Aug 2025Grant (prize money)$2M
- Sep 2024Grant (prize money)$1.4M
- Sep 2015Grant (prize money)$224.7K
- Sep 2014Grant (prize money)$188.1K
#9
Acquired · San Diego, California · founded 1996 · 348 employees$28.7Mraised▾
Develoeper of nucleic acid and mRNA products for research applications. The company offers a comprehensive product catalog focused on nucleic acids, mRNA reagents, and related tools for research, diagnostics, and therapeutics. It categories include nucleoside triphosphates (NTPs), modified nucleotides, capping analogs, enzymes, and kits.
- Mar 2025Grant (prize money)$12.7M
- Mar 2025Grant (prize money)$12.7M
- Jan 2015Grant (prize money)$132.8K
- Feb 2013Grant (prize money)$132.8K
#10
Funding Raised · San Diego, California · founded 2012$7.9Mraised▾
Developer of cell-processing systems to sort circulating tumor cells. The company pioneer in developing innovative cell-processing systems to sort, isolate, and manipulate circulating tumor cells (CTCs), stem cells, and immune cells in bulk-volume biological fluids (e.g. blood) for research and clinical applications.
- May 2025Grant (prize money)$2.4M
- Sep 2021Grant (prize money)$2.4M
- 2016Grant (prize money)$500K
- May 2015Grant (prize money)$650K
#11
Series A · San Diego, California · founded 2021 · 19 employees$29.2Mraised▾
Provider of single-cell multi-omics analysis platform for researchers. The company specializes in building tools and generating insights at the interface of biology, chemistry, and engineering. It offers multi-omic assays and the study of mechanistic insights into the RNA regulatory layer.
- Feb 2025Series A—
- Dec 2023Series A$23M
- Jan 2022Series A$6.2M
#12
Funding Raised · San Diego, California · founded 2002 · 6 employees$9.8Mraised▾
Thermostabilization platform enabling ambient storage of vaccines and sensitive biologics. It is a provider of stabilization and delivery enabling technologies. The company focuses on developing solutions for thermostabilizing vaccines and biologics, allowing for long-term storage, transport, and distribution without the need for cold chain infrastructure. This technology preserves the integrity of heat-labile vaccines and fragile biologics, enabling global access, especially in resource-limited settings. The company also develops novel mucosal and transdermal delivery systems. This impacts global health by ensuring medications can reach remote areas, even in extreme climates. The platform accelerates formulation, clinical testing, and market readiness by simplifying stability challenges early in drug development.
- Jan 2025Grant (prize money)$596.3K
- Jun 2021Grant (prize money)$596.3K
- Sep 2018Grant (prize money)$221.7K
- May 2015Grant (prize money)$1.6M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Platforms and Tools coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Bioinformatics is moving in the United States
A read on the academic research around Bioinformatics — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 13,110 United States-affiliated papers.
- Harvard University633
- Broad Institute433
- Howard Hughes Medical Institute318
- Stanford University287
- Johns Hopkins University287
- Gene83→532
- Transcriptome25→436
- Genome117→419
- Disease6→218
- Immune system11→219
- Disease17→407
- Immune system4→266
- Gene38→281
- Transcriptome13→238
- Biomarker2→208
- Disease27→311
- Immune system6→152
- Cancer17→130
- Clinical trial4→111
- Biomarker2→92
Where bioinformatics is researched across United States
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing bioinformatics patents in the United States
United States bioinformatics patent filing is accelerating — 246 filings from 64 assignees (2016–2025), led by Edico Genome, Illumina, UNIV Washington; annual filings 22→23.
- Edico Genome129
- Illumina60
- UNIV Washington18
- Nantomics9
- Baluch Mohamed Khoso7
- Genomsys7
- Microsoft6
- Contamination Source Identificat5
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.